Trial intelligence / Profile preview

Etomidate versus propofol for postoperative delirium and cognitive outcomes in elderly orthopedic surgery patients

IRCT20181206041866N1Phase 3Completed

Sponsor
Rafsanjan University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in delirium, confusion and pain comparing Propofol control with Etomidate intervention (2 arms). Primary endpoints: Postoperative pain, MMSE score and 2 more. Started Jan 2018; status: completed.

02

Drugs

etomidatepropofol
03

Conditions

deliriumconfusionpain

Beyond the preview

Go deeper on IRCT20181206041866N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181206041866N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call